The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer
- 27 April 2006
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (6) , 705-708
- https://doi.org/10.1136/jcp.2005.033217
Abstract
Background:The Glasgow Prognostic Score (GPS), an inflammation-based prognostic score formed from standard thresholds of C reactive protein (CRP) and albumin, has prognostic value in patients with advanced cancer. Little is known about the general biochemical disturbance associated with the systemic inflammatory response in cancer.Aim:To examine the relationship between the GPS and blood biochemistry in patients with advanced lung and gastrointestinal cancer.Methods:The GPS (albumin 10 mg/l = 1 combined to form a prognostic score of 0 (normal) and 1 or 2 (abnormal)) and a variety of biochemical variables were examined in patients (n = 50) with advanced lung or gastrointestinal cancer and in a healthy control group (n = 13).Results:The GPS was normal in all the controls, but abnormal in 78% of the cancer group. Serum levels of sodium, chloride, creatine kinase, zinc and vitamin D were lower in the cancer group (all pConclusion:Several correlations were seen between biochemical variables and increasing GPS. In particular, chronic activation of the systemic inflammatory response in cancer was associated with increase in γ-glutamyl transferase and alkaline phosphatase activity in patients with advanced lung and gastrointestinal cancer.Keywords
This publication has 15 references indexed in Scilit:
- A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancerBritish Journal of Cancer, 2005
- The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancerBritish Journal of Cancer, 2004
- Score Based on Hypoalbuminemia and Elevated C-Reactive Protein Predicts Survival in Patients With Advanced Gastrointestinal CancerNutrition and Cancer, 2004
- The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancerBritish Journal of Cancer, 2002
- The role of C-reactive protein as a prognostic indicator in advanced cancerCurrent Oncology Reports, 2002
- Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight LossNutrition and Cancer, 2001
- Changes in micronutrient concentrations following anti-inflammatory treatment in patients with gastrointestinal cancerPublished by Elsevier ,2000
- Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight LossNutrition and Cancer, 2000
- Clinical Survival Predictors in Patients With Advanced CancerArchives of internal medicine (1960), 2000
- Longitudinal Study of Weight, Appetite, Performance Status, and Inflammation in Advanced Gastrointestinal CancerNutrition and Cancer, 1999